147 related articles for article (PubMed ID: 1857308)
1. Developmentally disabled, doubly disadvantaged.
Parker G
Med J Aust; 1991 Jul; 155(2):68-71. PubMed ID: 1857308
[No Abstract] [Full Text] [Related]
2. Tardive dyskinesia and other drug-induced movement disorders among handicapped children and youth.
Gualtieri CT; Hawk B
Appl Res Ment Retard; 1980; 1(1-2):55-69. PubMed ID: 6121532
[No Abstract] [Full Text] [Related]
3. Psychoactive drug use in an institution for intellectually handicapped persons.
Sachdev PS
Med J Aust; 1991 Jul; 155(2):75-9. PubMed ID: 1677447
[TBL] [Abstract][Full Text] [Related]
4. Antiepileptic drugs with mood stabilizing properties and their relation with psychotropic drug use in institutionalized epilepsy patients with intellectual disability.
Leunissen CL; de la Parra NM; Tan IY; Rentmeester TW; Vader CI; Veendrick-Meekes MJ; Aldenkamp AP
Res Dev Disabil; 2011; 32(6):2660-8. PubMed ID: 21752594
[TBL] [Abstract][Full Text] [Related]
5. Problem behavior and psychiatric impairment within a developmentally disabled population. III: Psychotropic medication.
Jacobson JW
Res Dev Disabil; 1988; 9(1):23-38. PubMed ID: 3353539
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with psychotropic medication in mental retardation facilities.
Tu J; Smith JT
Compr Psychiatry; 1979; 20(3):289-95. PubMed ID: 446009
[No Abstract] [Full Text] [Related]
7. Psychotropic drug use in older developmentally disabled with behavioral difficulties.
Harper DC; Wadsworth JS; Michael AL
Res Dev Disabil; 1989; 10(1):53-60. PubMed ID: 2928579
[TBL] [Abstract][Full Text] [Related]
8. Adverse events and the relation with quality of life in adults with intellectual disability and challenging behaviour using psychotropic drugs.
Scheifes A; Walraven S; Stolker JJ; Nijman HL; Egberts TC; Heerdink ER
Res Dev Disabil; 2016; 49-50():13-21. PubMed ID: 26647003
[TBL] [Abstract][Full Text] [Related]
9. Psychopharmacology research for individuals with mental retardation: methodological issues and suggestions.
Matson JL; Bielecki J; Mayville SB; Matson ML
Res Dev Disabil; 2003; 24(3):149-57. PubMed ID: 12742384
[TBL] [Abstract][Full Text] [Related]
10. A study of the prescribing for people with learning disabilities living in the community and in National Health Service care.
Branford D
J Intellect Disabil Res; 1994 Dec; 38 ( Pt 6)():577-86. PubMed ID: 7881229
[TBL] [Abstract][Full Text] [Related]
11. Reducing psychotropic drug use in an institution for the retarded.
LaMendola W; Zabaria ES; Carver M
Hosp Community Psychiatry; 1980 Apr; 31(4):271-2. PubMed ID: 7390422
[No Abstract] [Full Text] [Related]
12. Observations on the psychopharmacology of the aged.
Eisdorfer C
J Am Geriatr Soc; 1975 Feb; 23(2):53-7. PubMed ID: 237957
[TBL] [Abstract][Full Text] [Related]
13. The administration of psychotropic and anticonvulsant drugs to children with profound intellectual disability and multiple impairments.
Hogg J
J Intellect Disabil Res; 1992 Dec; 36 ( Pt 6)():473-88. PubMed ID: 1477486
[TBL] [Abstract][Full Text] [Related]
14. Considerations in the use of psychotropic drugs in elderly mentally retarded persons.
Aman MG
J Ment Defic Res; 1990 Feb; 34 ( Pt 1)():1-10. PubMed ID: 2182880
[TBL] [Abstract][Full Text] [Related]
15. Psychotropic prescribing in people with intellectual disability and challenging behaviour.
Sheehan R; Strydom A; Morant N; Pappa E; Hassiotis A
BMJ; 2017 Aug; 358():j3896. PubMed ID: 28821479
[No Abstract] [Full Text] [Related]
16. Efficacy of lamotrigine in institutionalized, developmentally disabled patients with epilepsy: a retrospective evaluation.
Gidal BE; Walker JK; Lott RS; Shaw R; Speth J; Marty KJ; Rutecki P
Seizure; 2000 Mar; 9(2):131-6. PubMed ID: 10845738
[TBL] [Abstract][Full Text] [Related]
17. A critical appraisal of recent drug research in mental retardation: the Coldwater studies.
Aman MG; Singh NN
J Ment Defic Res; 1986 Sep; 30 ( Pt 3)():203-16. PubMed ID: 2878082
[TBL] [Abstract][Full Text] [Related]
18. Brief report: risperidone for severely disturbed behavior and tardive dyskinesia in developmentally disabled adults.
Khan BU
J Autism Dev Disord; 1997 Aug; 27(4):479-89. PubMed ID: 9261670
[No Abstract] [Full Text] [Related]
19. Effects of rationalizing drug treatment of patients with epilepsy and mental retardation.
Beghi E; Bollini P; Di Mascio R; Cerisola N; Merloni T; Manghi E
Dev Med Child Neurol; 1987 Jun; 29(3):363-9. PubMed ID: 3596072
[TBL] [Abstract][Full Text] [Related]
20. Psychotropic drugs and mental retardation: 1. Disabilities and the prescription of drugs for behaviour and for epilepsy in three residential settings.
Clarke DJ; Kelley S; Thinn K; Corbett JA
J Ment Defic Res; 1990 Oct; 34 ( Pt 5)():385-95. PubMed ID: 2266549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
